Infections associated with biliary drains

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 7, 1996, Pages 625-630

  Yu, Jian Lin ^a   Andersson, Roland ^a   Ljungh, Åsa ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT BYPASS; BILIARY TRACT DRAINAGE; ENDOPROSTHESIS; HUMAN; INCIDENCE; INFECTION SENSITIVITY; OBSTRUCTIVE JAUNDICE; PERCUTANEOUS TRANSHEPATIC DRAINAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; STENT; T TUBE;

EID: 0029767995     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609009140     Document Type: Review

References (89)

1. Edlund YA, Mollstedt BD, Ouchterlony O. Bacteriological investigation of the biliary system and liver in biliary tract disease correlated to clinical data and microstructure of the gall bladder and liver. Acta Chir Scand 1959;116:461-76.
2. Scott AJ. Bacteria and disease of the biliary tract. Gut 1971;12:487-42.
3. Csendes A, Fernandez M, Uribe P. Bacteriology of the gallbladder bile in normal subjects. Am J Surg 1975;129: 629-31.
4. Løveit T. Bacterial infections of the liver and biliary tract. Scand J Gastroenterol 1983; 18 Suppl 85:33-6.
5. Wells GR, Taylor EW, Lindsay G, Morton L, the West of Scotland Surgical Infection Study Group. Relationship between bile colonization, high-risk factors and postoperative sepsis in patients undergoing biliary tract operations while receiving a prophylactic antibiotic. Br J Surg 1989;76:374-7.
6. Brook I. Aerobic and anaerobic microbiology of biliary disease. J Clin Microbiol 1989;27:2373-5.
7. Dineen P. The importance of the route of infection in experimental biliary obstruction. Surg Gynecol Obstet 1964; 119:1001-6.
8. Nielsen ML. Route of infection in extrahepatic biliary tract disease. I. Experimental evidence against an entero-hepaticbiliary cycle of bacteria. Scand J Gastroenterol 1976; 10 Suppl 37:11-6.
9. Ong GB. A study of recurrent pyogenic cholangitis. Arch Surg 1962;84:199-225.
10. Orloff MJ, Peskin GW, Ellis HL. A bacteriologic study of human portal blood. Ann Surg 1956;148:738-46.
11. Schatten WE, Desprez JD, Holden WD. A bacteriologic study of portal-vein blood in man. Arch Surg 1955;71:404-9.
12. Nolan JP. Bacteria and the liver. N Engl J Med 1978;299: 1069-71.
13. Sung JY, Shaffer EA, Olson ME, Leung JWC, Lam K, Costerton JW. Bacterial invasion of the biliary system by way of the portal-venous system. Hepatology 1991;14:313-7.
14. Rosseland AR, Midtvedt T, Aasen AO. Gallbladder and duodenal bacterial flora after papillotomy in rabbits. Scand J Gastroenterol 1982;17:785-90.
15. Gregg JA, Girolami PD, Carr-Lock DL. Effects of sphincteroplasty and endoscopic sphincterotomy on the bacteriologic characteristics of the common bile duct. Am J Surg 1985;149: 668-71.
16. Donaldson RM. Normal bacterial populations of the intestine and their relation to intestinal function. N Engl J Med 1964; 270:938-45.
17. Thadepalli H, Lou SMA, Bach VT, Matsui TK, Mandal AK. Microflora of the human small intestine. Am J Surg 1979; 138:845-50.
18. Landor JH, Fulkerson CC. Duodenal diverticula. Relationship to biliary tract disease. Arch Surg 1966;93:182-8.
19. Eggert A, Teichmann W, Wittmann DH. The pathologic implication of duodenal diverticula. Surg Gynecol Obstet 1982; 154:62-4.
20. Løtveit T, Osnes M, Aune S, Larsen S. Studies of the choledochoduodenal sphincter in patients with and without juxta-papillary duodenal diverticula. Scand J Gastroenterol 1980;15:875-80.
21. Løtveit T, Foss OP, Osnes MC. Biliary pigment and cholesterol calculi in patients with and without juxtapapillary duodenal diverticula. Scand J Gastroenterol 1981;16:241-4.
22. Løtveit T, Osnes M, Larsen S. Recurrent biliary calculi. Duodenal diverticula as a predisposing factor. Ann Surg 1982; 196:30-2.
23. Geoghegan JG, Branch MS, Costerton JW, Pappas TN, Cotton PB. Biliary stent occlude earlier if the distal tip is in the duodenum in dogs. Gastrointest Endosc 1991;37:257-61.
24. Sung JY, Leung JWC, Shaffer EA, Lam K, Olson ME, Costerton JW. Ascending infection of the biliary tract after surgical sphincterotomy and biliary stenting. J Gastroenterol Hepatol 1992;7:240-5.
25. Dorairajan N. Infective complications of biliary surgery. HPB Surg 1992;5 Suppl:106.
26. Keighley MRB, Lister DM, Jacobs SI, Giles GR. Hazards of surgical treatment due to microorganisms in the bile. Surgery 1974;75:578-83.
27. Nilsson U, Evander A, Ihse I, Lunderquist A, Mocibob A. Percutaneous transhepatic cholangiography and drainage. Acta Radiol 1983;24:433-9.
28. Soehendra N, Reynders-Frederix V. Palliative bile duct drainage - a new endoscopic method of introducing a transpapilliary drain. Endoscopy 1980;12:8-11.
29. Huibregtse K, Katon RM, Tytgat GNJ. Endoscopic treatment of postoperative biliary strictures. Endoscopy 1986;18:133-7.
30. Huibregtse K, Katon RM, Coene PP, Tytgat GNJ. Endoscopic palliative treatment in pancreatic cancer. Gastrointest Endosc 1986;32:334-8.
31. Cotton PB, Forbes A, Leung JWC, Dineen L. Endoscopic stenting for long-term treatment of large bile duct stones: 2- to 5-year follow up. Gastrointest Endosc 1987;33:411-2.
32. Ponchon T, Gallez JF, Valette PJ, Chavaillon A, Boty R. Endoscopic treatment of biliary tract fistulas. Gastrointest Endosc 1989;35:490-8.
33. Cotton PB. Management of malignant bile duct obstruction. J Gastroenterol Hepatol 1990 Suppl 1:63-77.
34. Speer AG, Cotton PB, Rode J, Seddon AM, Neal CR, Holton J, et al. Biliary stent blockage with bacterial biofilm. a light and electron microscopy study. Ann Intern Med 1988;108:546-53.
35. Coene PPLO, Groen AK, Cheng J, Out MMJ, Tytgat GNJ, Huibregtse K. Clogging of biliary endoprostheses: a new perspective. Gut 1990;31:913-7.
36. Dowidar N, Kolmos HJ, Lyon H, Matzen P. Clogging of biliary endoprostheses. A morphologic and bacteriologic study. Scand J Gastroenterol 1991;26:1137-44.
37. Dowidar N, Moesgaard F, Matzen P. Clogging and other complications of endoscopic biliary endoprostheses. Scand J Gastroenterol 1991;26:1132-6.
38. Naggar E, Krag E, Matzen P. Endoscopically inserted biliary endoprostheses in malignant obstructive jaundice: a survey of the literature. Liver 1990;10:321-4.
39. Dickinson GM, Bisno AL. Infections associated with indwelling devices: concepts of pathogenesis; infections associated with intravascular devices. Antimicrob Agents Chemother 1989;33: 597-601.
40. Westerlund B, Korhonen TK. Bacterial proteins binding to the mammalian extracellular matrix. Mol Microbiol 1993;9:687-94.
41. Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun 1982;37:318-26.
42. Govan JRW, Fyfe JAM. Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid form to carbenicillin, flucloxacillin, tobramycin and the isolation of mucoid variants in vitro. J Antimicrobial Chemother 1978;4:233-40.
43. Vaudaux PE, Zulian G, Huggler E, Waldvogel FA. Attachment of Staphylococcus aureus to polymethylmethacrylate increases its resistance to phagocytosis in foreign body infection. Infect Immun 1985;50:472-7.
44. Costerton JW, Watkins L. Adherence of bacteria to foreign bodies: the role of the biofilms. In: Root RK, Trunkey DD, Sande MA, editors. New surgical and medical approaches in infectious diseases. New York: Elsevier Press, 1987:17-30.
45. Johnson GM, Lee DA, Regelmann WE, Gray ED, Peters G. Quie PG. Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun 1986;54:13-20.
46. Gray ED, Peters G, Verstegen M, Regelmann WE. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet 1984;1: 365-7.
47. Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 1987;237:1588-95.
48. Christensen GD, Baddour LM, Hasty DL, Lowrance JH, Simpson WA. Microbial and foreign body factors in the pathogenesis of medical device infections. In: Bisno AL, Waldvogel FA, editors. Infection associated with indwelling medical devices. Washington [DC]: American Society of Microbiology Press, 1989:41-59.
49. O'Connor MJ, Allen JI, Vennes JA, McCarthy JB, Furcht LT. Protective effects of fibronectin in bile against biliary infection. Surg Forum 1984;35:122-4.
50. Wilton PB, Dalmasso AP, Allen MO. Complement in local biliary tract defense: dissociation between bile complement and acute phase reactants in cholecystitis. J Surg Res 1987;42: 434-9.
51. Mosher DF, editor. Fibronectin. San Diego [CA]: Academic Press, 1989.
52. Tamkun JW, Hynes RO. Plasma fibronectin is synthesized and secreted by hepatocytes, J Biol Chem 1983;258:4641-7.
53. Paul JI, Hynes RO. Multiple fibronectin subunits and their posttranslational modifications. J Biol Chem 1984;259:13477-13488.
54. Chijiiwa K, Koga A, Yamasaki T, Shimada K, Noshiro H, Nakayama F. Fibronectin: a possible factor promoting cholesterol monohydrate crystallization in bile. Biochim Biophys Acta 1991;1086:44-8.
55. Miquel JF, von Ritter C, Pozo RD, Lange V, Jungst D, Paumgartner G. Fibronectin in human gallbladder bile: cholesterol pronucleatin and/or mucin 'link' protein. Am J Physiol 1994;267:G393-400.
56. Yu JL, Ljungh Å, Andersson R, Jakab E, Bengmark S, Wadström T. Promotion of Escherichia coli adherence to rubber slices by adsorbed fibronectin J Med Microbiol 1994;41:133-8.
57. Yu JL, Andersson R, Wang LQ, Bengmark S, Ljungh Å. Fibronectin on the surface of biliary drain material - a role in bacterial adherence. J Surg Res 1995;59:596-600.
58. Yu JL, Andersson R, Ljungh Å. Protein adsorption and bacterial adhesion to biliary drain materials. J Surg Res 1996. In press.
59. Kolb WP, Müller-Eberhard HJ. The membrane attachment mechanism of complement: isolation and subunit composition of the C5b-complex. J Exp Med 1975;141:724-35.
60. Holmes R. Preparation from human serum of an alpha-on protein which induces the immediate growth of unadapted cells in vitro. J Cell Biol 1967;32:297-308.
61. Preissner KT. Structure and biological role of vitronectin. Ann Rev Cell Biol 1991;7:275-310.
62. Barnes DW, Silntzer J, See C, Shaffer M. Characterization of human serum spreading factor with monoclonal antibody. Proc Natl Acad Sci USA 1983;80:1362-6.
63. Høgåsen K, Mollnes TE, Tschopp J, Harboe M. Quantitation of vitronectin and clusterin: pitfalls and solutions in enzyme immunoassay for adhesive proteins. J Immunol Methods 1993; 160:107-15.
64. Conlan MG, Tomasini BR, Schultz RL, Mosher D. Plasma vitronectin polymorphism in normal subjects and patients with disseminated intravascular coagulation. Blood 1988;72:185-90.
65. Pohl WR, Conlan MG, Thompson AB, Ertl RF, Romberger DJ, Mosher DF, et al. Vitronectin in bronchoalveolar lavage fluid is increased in patients with interstitial lung disease. Am Rev Respir Dis 1991;143:1369-75.
66. Teschler H, Pohl WR, Thompson AB, Konietzko L, Mosher DF, Costabel U, et al. Elevated levels of bronchoalveolar lavage vitronectin in hypersensitivity pneumotitis. Am Rev Respir Dis 1993;147:332-7.
67. Hayman EG, Pierschbacher MD, Oehgren Y, Ruoslahti E. Serum spreading factor (vitronectin) is present at the cell surface and in tissue. Proc Natl Acad Sci USA 1983;80:4003-7.
68. Chhatwal GS, Preissner KT, Müller-Berghaus G, Blobel H. Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus and Escherichia coli. Infect Immun 1987;55:1878-83.
69. Wadström T, Ljungh Å, Flock J-I. Vitronectin binding surface proteins of staphylococci and Helicobacter pylori. In: Preissner KT, Rosenblatt S, Kost C, Wegerhoff J, Mosher DF, editors. Biology of vitronectins and their receptors. Amsterdam: Excepta Medica, 1993:257-63.
70. Leung JWC, Ling TWK, Kung JLS, Vallance-Owen J. The role of bacteria in the blockage of biliary stent. Gastrointest Endosc 1988;34:19-22.
71. Dowidar N, Kolmos HJ, Matzen P. Experimental clogging of biliary endoprostheses: role of bacteria, endoprosthesis material, and design. Scand J Gastroenterol 1992;27:77-80.
72. Maki T. Pathogenesis of calcium bilirubinate gallstones: role of E. coli, β-glucuronidase and coagulation by inorganic ions, polyelectrolytes and agitation. Ann Surg 1966;164:90-100.
73. Safrany L, Schrameyer B, Wosiewitz U. Analysis of causes of the occlusion of biliary stents. Gastrointest Endose 1986;32: 183A.
74. McAllister EW, Carey LC, Brady PG, Heller R, Kovacs SG. The role of polymeric surface smoothness of biliary stents in bacterial adherence, biofilm deposition, and stent occlusion. Gastrointest Endosc 1993;39:422-5.
75. Jansen B, Goodman LP, Ruiten D. Bacterial adherence to hydrophilic polymer-coated polyurethane stents. Gastrointest Endosc 1993;39:670-3.
76. Smit JM, Out MMJ, Greon AK, Huibregtse K, Jansen PLM, van Marie J, et al. A placebo-controlled study on the efficacy of aspirin and doxycycline in preventing clogging of biliary endoprostheses. Gastrointest Endosc 1989;35:485-9.
77. Rey JF, Maupetit P, Greff M. Experimental study of biliary endoprosthesis efficiency. Endoscopy 1985;17:145-8.
78. Sheth NK, Rose HD, Franson TR, Buckmire FL, Sohnle PG. In vitro quantitative adherence of bacteria to intravascular catheters. J Surg Res 1983;34:213-8.
79. Hogt AH, Dankert J, de Vries A, Feijen J. Adhesion of coagulase-negative staphylococci to biomaterials. J Gen Microbiol 1983;129:2959-68.
80. Harris JM, Martin LF. An in vitro study of the properties influencing Staphylococcus epidermidis adhesion to prosthetic vascular graft material. Ann Surg 1987;206:612-20.
81. Colburn MD, Moore WS, Chvapil M, Gelabert HA, QuinonesBaldrich WJ. Use of an antibiotic-bonded graft for in situ reconstruction after prosthetic graft infections. J Vasc Surg 1992;16:651-8.
82. Paulsson M, Kober M, Freij-Larsson C, Stollenwerk M, Wesslen B, Ljungh Å. Adhesion of staphylococci to chemically modified and native polymers, and the influence of preadsorbed fibronectin, vitronectin and fibrinogen. Biomaterials 1993;14: 845-53.
83. Sugarman B, Musher D. Adherence of bacteria to suture materials. Proc Soc Exp Biol Med 1981;167:156-60.
84. Ludwicka A, Jansen B, Wadström T, Pulverer G. Attachment of staphylococci to various synthetic polymers. Zentralhl Bakteriol [A] 1984;256:479-89.
85. Coene PLO. Endoscopic biliary stenting [thesis]. Amsterdam: University of Amsterdam, 1990.
86. Sawant AD, Gabriel M, Mayo MS, Ahearn DG. Radiopacity additives in silicone stent materials reduce in vitro bacterial adherence. Current Microbiol 1991;22:285-92.
87. Leung JWC, Lau GTC, Sung JJY, Costerton JW. Decreased bacterial adherence to silver-coated stent material: an in vitro study. Gastrointest Endosc 1992;38:338-40.
88. Ishihara K, Oshida H, Endo Y, Watanabe A, Ueda T, Nakabayashi N. Effects of phospholipid adsorption on nonthrombogenicity of polymer with phospholipid polar group. J Biomed Mater Res 1993;27:1309-14.
89. Yu JL, Andersson R, Ljungh Å, Wang LQ, Jakab E, Persson BG, et al. Reduction of E. coli adherence to rubber slices treated with phospholipids. APMIS 1993;101:582-6.